Morphologic pattern of tenascin as a diagnostic biomarker in colon cancer

Journal of Surgical Oncology

Volumn 64, Issue 2, 1997, Pages 98-101

  Iskaros, Basem F ^a   Tanaka, Kathryn E ^a   Hu, Xiaoping ^a   Kadish, Anna S ^a   Steinberg, Jacob J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

adhesion molecule; extracellular matrix; glycoprotein

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; TENASCIN;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; AGED; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STAINING AND LABELING; SURVIVAL ANALYSIS; TENASCIN; TUMOR MARKERS, BIOLOGICAL;

EID: 0031028941     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199702)64:2<98::AID-JSO2>3.0.CO;2-J     Document Type: Article

References (17)

1. Vrucinic-Filipi N, Chiquet-Ehrismann R: Tenascin function and regulation of expression. Symp Soc Exp Biol 1993;47:155-162.
2. Sakai T, Kawakatsu H, Hirota N, et al.: Specific expression of tenascin in human colonic neoplasms. Br J Cancer 1993;67(5): 1058-1064.
3. Riedl SE, Faissner A, Schlag P, et al.: Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. Gastroenterology 1992;103:400-406.
4. Siegal GP, Wang MH, Rinehart CA Jr, et al.: Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells. Cancer Letters 1993;69:123-132.
5. Moch H, Torhorst J, Durmuller U, et al.: Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer. Pathol Res Pract 1993;189:510-514.
6. Shoji T, Kamiya T, Tsubura A, et al.: Tenascin staining positivity and the survival of patients with invasive breast carcinoma. J Surg Res 1993;55:295-297.
7. Nakanishi H, Oguri K, Takenaga K, et al.: Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells. Lab Invest 1994;70:324-332.
8. Tremble P, Chiquet-Ehrismann R, Werb Z: The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell 1994;5: 439-453.
9. Sugawara I, Hirakoshi J, Kusakabe M, et al.: Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma. Jpn J Cancer Res 1993;84:703-707.
10. Barsky SH, Gopalakrishna R: Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res 1987;47:1663-1667.
11. Chiquet-Ehrismann R: Tenascin and other adhesion-modulating proteins in cancer [Review]. Semin Cancer Biol 1993;4:301-310.
12. Natali PG, Nicotra MR, Bigotti A, et al.: Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int J Cancer 1991;47: 811-816.
13. Walker RA, Dearing SJ, Gallacher B: Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer 1994;69:1160-1165.
14. Chiquet-Ehrismann R, Kalla P, Pearson CA: Participation of tenascin and transforming growth factor-beta in reciprocal epithelial-mesenchymal interaction of MCF7 cells and fibroblasts. Cancer Res 1989;49:4322-4325.
15. Sakai T, Kawakatsu H, Ohta M, Saito M: Tenascin induction in tenascin nonproducing carcinoma cell lines in vivo and by TGF-beta 1 in vitro. J Cell Physiol 1994;159:561-572.
16. Hart IR, Goode NT, Wilson RE: Molecular aspects of the metastatic cascade [Review]. Biochim Biophys Acta 1989;989:65-84.
17. Blood CH, Zetter BR: Tumor interaction with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1990; 1032:89-118.